16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use

Details for Australian Patent Application No. 2009217824 (hide)

Owner AstraZeneca AB

Inventors Andersson, Paul; Mussie, Tesfaledet; Ivanova, Svetlana; Bhattacharyya, Sumita; Burkamp, Frank; Bladh, Hakan; Lepisto, Matti

Agent Freehills

Pub. Number AU-A-2009217824

PCT Pub. Number WO2009/108118

Priority 61/031,801 27.02.08 US

Filing date 27 February 2009

Wipo publication date 3 September 2009

International Classifications

C07J 71/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

12 August 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use 2010

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/108118 Priority application(s): WO2009/108118

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217839-System for aroma release

2009217823-Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177